Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Dorzolamide (2% w/v) + Timolol (0.5% w/v) Eye Drop
Therapeutic Category
Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Dorshell T Eye Drop (Dorzolamide 2% + Timolol 0.5%) is a premium, high-profit chronic care product built for our PCD Pharma Franchise partners.
This Fixed-Dose Combination (FDC) is one of the most essential and widely prescribed drugs in ophthalmology. It combines the effective aqueous humor reduction of a CAI (Dorzolamide) with the production suppression of a Beta-Blocker (Timolol), offering maximum Intraocular Pressure (IOP) reduction in a single bottle.
Why Dorshell T is Your Key to Profit:
Guaranteed Recurring Revenue: FDCs are the preferred choice for glaucoma due to enhanced patient compliance (fewer drops daily). This ensures stable, long-term prescription refills and excellent financial stability.
Maximum Specialty Margin: Positioned as a specialized FDC in the high-value ophthalmic segment, this product commands premium pricing and secures some of the highest profit margins in chronic eye care.
Superior Clinical Value: The combination is highly rational and clinically necessary for patients who need aggressive IOP lowering. This built-in efficacy drives strong, reliable specialist loyalty.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition for this specific, high-demand FDC formulation. Partner with us for full marketing support to secure high-value, recurring prescriptions and guaranteed business growth.
Contact us today to capture this max-margin specialty segment!
The eye drop is generally well-tolerated. Mild side effects may include temporary stinging, burning, or slight redness upon application. Rarely, allergic reactions such as itching, swelling, or increased irritation may occur. Discontinue use and consult a healthcare professional if severe reactions develop.
Lubicom Ultra Eye Drop is indicated for relief from dry eyes, irritation, and oxidative stress-related ocular discomfort. It helps in lubricating the eyes, protecting against free radical damage, and improving overall eye health. It may also support visual clarity and reduce age-related oxidative changes in the eyes.
Use Lubicom Ultra Eye Drop exactly as directed. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. This product is for ocular use only and should not be swallowed.
Store Lubicom Ultra Eye Drop in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children. Discard any unused solution after the expiry date.
Composition : Torsemide 10mg Tablet
Composition : Torsemide 100mg Tablet
Composition : Torsemide 20 mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Torsemide 5mg Tablet
Composition : Torsemide (10mg/ml) Injection
Composition : Torsemide 5 mg + Spironolactone 50 mg Tablet
Composition : TORSEMIDE 10 MG + SPIRONOLACTONE 25 MG
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Chlorthalidone 6.25mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This ophthalmic combination is widely used in glaucoma management, making it a strong prescription eye-care product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in glaucoma treatment, ocular hypertension, and long-term intraocular pressure control. It is commonly prescribed by ophthalmologists for chronic eye-care management and requires continuous patient use.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Dorzolamide 2% + Timolol Maleate 0.5% Eye Drops with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady chronic prescription demand, repeat monthly usage by glaucoma patients, and strong acceptance in ophthalmology practice when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, and distribution support services.